Skip to main content

Failure to Thrive and Nasal Obstruction

  • Chapter
  • First Online:
Pediatric Immunology

Abstract

Patients with infection caused by unusual or catalase-positive organisms such as Serratia marcescens should be evaluated for chronic granulomatous disease (CGD)

X-linked CGD caused by mutations in CYBB (gp91phox) is the most common form

Dihydrorhodamine test assay has replaced the NBT test as first choice for establishing a diagnosis of CGD

CGD is also a disorder of auto-inflammation, associated with inflammatory bowel disease and lung granuloma

Antibiotic prophylaxis is essential for all CGD patients

Stem cell transplant is curative and should be offered to patients with severe phenotype

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chronic granulomatous disease: clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27(3):242–53.

    Article  Google Scholar 

  2. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79(3):155–69.

    Article  CAS  Google Scholar 

  3. Mirra V, Werner C, Santamaria F. Primary ciliary dyskinesia: an update on clinical aspects, genetics, diagnosis, and future treatment strategies. Front Pediatr. 2017;5:135.

    Article  Google Scholar 

  4. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci. 2012;1250:50–5.

    Article  CAS  Google Scholar 

  5. Leiding JW, Holland SM. Chronic granulomatous disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle: University of Washington, Seattle; 2016. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

    Google Scholar 

  6. Dotta L, Parolini S, Prandini A, Tabellini G, Antolini M, Kingsmore SF, Badolato R. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis. 2013;8:168.

    Article  Google Scholar 

  7. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol. 2004;113(4):620–6.

    Article  CAS  Google Scholar 

  8. Meher-Homji Z, Mangalore RP, Johnson DR, Chua YL. Chromobacterium violaceum infection in chronic granulomatous disease: a case report and review of the literature. JMM Case Rep. 2017;4(1):e005084.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rodriguez, D., Dunham, M.E., Wall, L.A. (2019). Failure to Thrive and Nasal Obstruction. In: Rezaei, N. (eds) Pediatric Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-21262-9_62

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21262-9_62

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21261-2

  • Online ISBN: 978-3-030-21262-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics